MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)
Clinical trial NCT07042945 · COMPLETED
Trial details
- NCT number
- NCT07042945
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-09
- Primary completion
- 2026-06-05
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.